ACCD Jun 2024 10.000 call
| Previous close | 0.1000 |
| Open | 0.1000 |
| Bid | 0.0500 |
| Ask | 0.1500 |
| Strike | 10.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.1000 - 0.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.47k |
GlobeNewswireAccolade To Present at William Blair Growth Stock Conference
SEATTLE, May 29, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the William Blair Growth Stock Conference in Chicago on Tuesday, June 4 at 2:00 pm CT. A webcast will be available at ir.accolade.com and a replay will be available for 90 days. About Accolade, Inc. Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthi
PR NewswireAccolade Welcomes Noom to Trusted Partner Ecosystem
Accolade, Inc. (Nasdaq: ACCD) announced today that Noom has joined Accolade's Trusted Partner Ecosystem to provide customers with a comprehensive solution for weight loss and metabolic health, including support for GLP-1s and other anti-obesity medications. In addition to the standard integrated features that drive appropriate Trusted Partner utilization, Noom's clinical obesity management solution, Noom Med, will be powered by Accolade physicians extensively trained in weight loss protocols and
Insider MonkeyAccolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript
Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript April 25, 2024 Accolade, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.11. Accolade, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and thank you for standing by. […]
